AKT1 and cancer: BCP modulates multiple pathways involved in cancer pathogenesis including MAPK, PI3K/AKT/mTOR/S6K1, and STAT3 (Figure 2), activates cytotoxic pathways against tumors, potentiates pathways that hinder metastasis, reduces the expression of oncogenes and proteins, and simultaneously increases genes and proteins that destroy cancer cells [34–37].